Y Uto
Overview
Explore the profile of Y Uto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ariizumi H, Saito B, Uto Y, Hattori N, Nakashima H, Yanagisawa K, et al.
Bone Marrow Transplant
. 2014 Oct;
50(2):301-3.
PMID: 25347005
No abstract available.
2.
Matsumoto C, Uto Y, Muranaga F, Kumamoto I
Methods Inf Med
. 2013 Sep;
52(6):522-35.
PMID: 24072039
Objective: The purpose of this study was to improve accessibility to nursing care by clarifying the relationship between patient characteristics and the amount of nursing care for the Diagnosis Procedure...
3.
Muranaga F, Kumamoto I, Uto Y
Methods Inf Med
. 2007 Dec;
46(6):679-85.
PMID: 18066419
Objectives: To develop a data warehouse system for cost analysis, based on the categories of the diagnosis procedure combination (DPC) system, in which medical costs were estimated by DPC category...
4.
Miyoshi A, Kitajima Y, Ide T, Ohtaka K, Nagasawa H, Uto Y, et al.
Int J Oncol
. 2006 Nov;
29(6):1533-9.
PMID: 17088993
Tumor hypoxia has been reported to induce tumor progression in several carcinomas. Current studies have shown that hypoxia inducible factor-1alpha (HIF-1alpha) is stabilized under hypoxic conditions and transactivates various genes...
5.
Masunaga S, Sakurai Y, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, et al.
Br J Radiol
. 2006 Aug;
79(948):991-8.
PMID: 16916808
We clarified the usefulness of the continuous administration of tirapazamine (TPZ) in combination with reduced dose-rate irradiation (RDRI) using gamma-rays or reactor thermal neutrons. Squamous cell carcinoma (SCC) VII tumour-bearing...
6.
Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, et al.
Int J Hyperthermia
. 2005 Jul;
21(4):305-18.
PMID: 16019857
To evaluate the usefulness of continuous administration of hypoxic cytotoxins in terms of targeting acute hypoxia in solid tumours and the significance of combination with mild temperature hyperthermia (MTH) (40...
7.
Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, et al.
Appl Radiat Isot
. 2004 Aug;
61(5):953-8.
PMID: 15308174
We evaluated the usefulness of five new (10)B-compounds (TX-2016, TX-2017, TX-2018, TX-2041, and TX-2042) as (10)B-carriers in boron neutron capture therapy (BNCT). They are 2-nitroimidazole-sodium borocaptate-(10)B (BSH) conjugates, that is,...
8.
Shimamura M, Nagasawa H, Ashino H, Yamamoto Y, Hazato T, Uto Y, et al.
Br J Cancer
. 2003 Mar;
88(2):307-13.
PMID: 12610518
Tumour angiogenesis is initiated by angiogenic factors that are produced in large amounts by hypoxic tumour cells. The inhibition of this step may lead to tumour-specific antiangiogenesis because normal tissues...
9.
Masunaga S, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, et al.
Jpn J Cancer Res
. 2001 Sep;
92(9):996-1007.
PMID: 11572769
C57BL mice bearing EL4 tumors and C3H / He mice bearing SCC VII tumors received 5-bromo-2'-deoxyuridine (BrdU) continuously for 5 days via implanted mini-osmotic pumps to label all proliferating (P)...
10.
Masunaga S, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, et al.
Int J Radiat Oncol Biol Phys
. 2001 Jun;
50(4):1063-72.
PMID: 11429234
Purpose: To evaluate the radiosensitization effect on solid tumors upon combination treatment with paclitaxel (TXL), including the effect on intratumor quiescent (Q) cells. Methods And Materials: Mice bearing SCC VII...